Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

57.1%

4 terminated/withdrawn out of 7 trials

Success Rate

42.9%

-43.6% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(50.0%)
Phase 4
1(16.7%)
N/A
1(16.7%)
Phase 3
1(16.7%)
6Total
Phase 1(3)
Phase 4(1)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT02609126Phase 1Completed

Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoarthritis

Role: collaborator

NCT03813316Phase 4Withdrawn

Approaches To Therapy Escalation In T2D

Role: collaborator

NCT02499068Not ApplicableCompleted

Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring

Role: collaborator

NCT02391935Phase 1Completed

Study of Intradermal Injections of RCS-01 in Male and Female Subjects

Role: collaborator

NCT02330146Phase 1Terminated

Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

Role: collaborator

NCT01762644Phase 3Withdrawn

The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients

Role: collaborator

NCT02655042Withdrawn

Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

Role: collaborator

All 7 trials loaded